Arkolith/Insider Trading/ALDX/Form 4

Douglas Richard

DirectorAldeyra Therapeutics, Inc. (ALDX) · full profile →Form 4 · filed Mar 20, 2026
Net Buying
Open-Market Buys
$98K
Open-Market Sells
$0
Net Open-Market Flow
$98K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 19, 2026Buy(P)70K$1.40$98K195K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-26-117675) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML